HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Factor Va is inactivated by activated protein C in the absence of cleavage sites at Arg-306, Arg-506, and Arg-679.

Abstract
Activated protein C (APC) exerts its anticoagulant activity via proteolytic degradation of the heavy chains of activated factor VIII (FVIIIa) and activated factor V (FVa). So far, three APC cleavage sites have been identified in the heavy chain of FVa: Arg-306, Arg-506, and Arg-679. To obtain more insight in the structural and functional implications of each individual cleavage, recombinant factor V (rFV) mutants were constructed in which two or three of the APC cleavage sites were mutated. After expression in COS-1 cells, rFV mutants were purified, activated with thrombin, and inactivated by APC. During this study we observed that activated rFV-GQA (rFVa-GQA), in which the arginines at positions 306, 506, and 679 were replaced by glycine, glutamine, and alanine, respectively, was still inactivated by APC. Further analysis showed that the inactivation of rFVa-GQA by APC was phospholipid-dependent and sensitive to an inhibitory monoclonal antibody against protein C. Inactivation proceeded via a rapid phase (kx1=5.4 x 10(4) M(-1) s(-1)) and a slow phase (kx2=3.2 x 10(3) M(-1) s(-1)). Analysis of the inactivation curves showed that the rapid phase yielded a reaction intermediate that retained approximately 80% of the original FVa activity, whereas the slow cleavage resulted in formation of a completely inactive reaction product. Inactivation of rFVa-GQA was accelerated by protein S, most likely via stimulation of the slow phase. Immunoblot analysis using a monoclonal antibody recognizing an epitope between Arg-306 and Arg-506 indicated that during the rapid phase of inactivation a fragment of 80 kDa was generated that resulted from cleavage at a residue very close to Arg-506. The slow phase was associated with the formation of fragments resulting from cleavage at a residue 1.5-2 kDa carboxyl-terminal to Arg-306. Our observations may explain the unexpectedly mild APC resistance associated with mutations at Arg-306 (FV HongKong and FV Cambridge) in the heavy chain of FV.
AuthorsMarijn van der Neut Kolfschoten, Richard J Dirven, Hans L Vos, Guido Tans, Jan Rosing, Rogier M Bertina
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 279 Issue 8 Pg. 6567-75 (Feb 20 2004) ISSN: 0021-9258 [Print] United States
PMID14660667 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Epitopes
  • Phospholipids
  • Protein C
  • Protein S
  • Recombinant Proteins
  • Glutamine
  • Factor Va
  • Factor VIIIa
  • Arginine
  • Thrombin
  • Glycine
Topics
  • Animals
  • Antibodies, Monoclonal (chemistry)
  • Arginine (chemistry)
  • Binding Sites
  • COS Cells
  • Electrophoresis, Polyacrylamide Gel
  • Epitopes
  • Factor VIIIa (chemistry)
  • Factor Va (chemistry)
  • Glutamine (chemistry)
  • Glycine (chemistry)
  • Humans
  • Immunoblotting
  • Kinetics
  • Mutagenesis
  • Mutation
  • Phospholipids (chemistry)
  • Protein Binding
  • Protein C (chemistry, metabolism)
  • Protein S (chemistry)
  • Protein Structure, Tertiary
  • Recombinant Proteins (chemistry)
  • Temperature
  • Thrombin (chemistry)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: